Development of a Scoring Model to Predict Completion of Chemoradiotherapy for Inoperable Stage III NSCLC

Development of a Scoring Model to Predict Completion of Chemoradiotherapy for Inoperable Stage III NSCLC - Scoring Model to Predict Completion of Chemoradiotherapy for Stage III NSCLC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054100

Enrollment

1288

Registered

2024-04-10

Start date

2024-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inoperable Stage III Non-Small Cell Lung Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study will include 1288 patients enrolled in the CRT dataset stored in the Japan Lung Cancer Society Integrated Database of Clinical Trials (JIDB). The following cases are selected from JIDB. (1) Patients who received concurrent radiation and chemotherapy (2) Patients who were diagnosed with unresectable locally advanced non-small cell lung cancer

Exclusion criteria

Exclusion criteria: Exclude the following cases. (1) Cases in which completion of treatment was not noted.

Design outcomes

Primary

Measure	Time frame
Percentage of treatment completed = Percentage of protocol treatment completed for each study	—

Countries

Japan

Contacts

Public ContactMasato Karayama

Hamamatsu University School of Medicine Cancer Center

karayama@hama-med.ac.jp053-435-2491

Outcome results